Quotables
"The production of too many useful things results in too many useless people."
Karl Marx
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110311620 | NOVEL MODIFIED RELEASE DOSAGE FORMS OF XANTHINE OXIDOREDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.... | 12/22/2011 |
| 20110287097 | PHARMACEUTICAL COMPOSITIONS COMPRISING ROPINIROLE Controlled release pharmaceutical compositions comprising ropinirole or pharmaceutically acceptable salts thereof, wherein embodiments have ropinirole embedded in a matrix comprising one or more polymers, and the composition in monolithic form or in multiparticulate for... | 11/24/2011 |
| 20110287096 | MODIFIED GASTRORETENTIVE DRUG DELIVERY SYSTEM FOR AMINE DRUGS Oral dosage forms for basic amine drugs, the dosage forms having a gastro-retentive component and a non gastro-retentive component. These dosage forms are capable of providing both IR and SR release rates for these drugs. In addition, they provide for release of the dru... | 11/24/2011 |
| 20110223247 | PHARMACEUTICAL COMPOSITIONS FOR RELEASE CONTROL OF METHYLPHENIDATE Disclosed is a pharmaceutical composition for release control comprising a plurality of particles for release control. The plurality of particles for release control comprise a core material containing methylphenidate and a polymer coating layer for release control form... | 09/15/2011 |
| 20110165234 | EXTENDED RELEASE VENLAFAXINE FORMULATION A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.... | 07/07/2011 |
| 20100285120 | CONTROLLED RELEASE PREPARATION A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, g... | 11/11/2010 |
| 20100086589 | EXTENDED RELEASE PELLET FORMULATION CONTAINING PRAMIPEXOLE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF An extended release pellet comprising an active ingredient selected from pramipexole and the pharmaceutically acceptable salts thereof, and at least one release-modifying excipient.... | 04/08/2010 |
| 20100047343 | MULTIPARTICULATE FORMULATION HAVING TRAMADOL IN IMMEDIATE AND CONTROLLED RELEASE FORM A multi-particulate pharmaceutical composition of rapid release particles and controlled release particles comprising tramadol or a salt thereof is provided. The composition provides a rapid and controlled release of tramadol or a salt thereof in a substantially pH inde... | 02/25/2010 |
| 20100047342 | Method and Composition for Administering an NMDA Receptor Antagonist to a Subject The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.... | 02/25/2010 |
| 20090263478 | CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF Disclosed are amorphous carvedilol salt forms, controlled-release carvedilol compositions, and methods of preparing the forms and compositions.... | 10/22/2009 |
| 20090258066 | COMPOSITIONS COMPRISING WEAKLY BASIC DRUGS AND CONTROLLED-RELEASE DOSAGE FORMS The present invention is directed to pharmaceutical compositions, and methods of making such compositions, comprising microparticles containing a weakly basic drug core, a layer of alkaline buffer, and a controlled-release coating. The present invention is also directed... | 10/15/2009 |
| 20090220593 | EXTENDED RELEASE DOSAGE FORMS OF QUETIAPINE The present invention relates to multiple unit extended release dosage forms of quetiapine for oral administration, wherein each unit comprises a core containing quetiapine and one or more of pharmaceutically acceptable excipients coated with a rate-controlling coating ... | 09/03/2009 |
| 20090208570 | Extended Release Dosage forms of Metoprolol The present invention relates to extended release dosage forms of metoprolol or salts thereof comprising a water insoluble and non-swellable inert core and one or more pharmaceutically acceptable excipients. The invention also relates to processes for the preparation of... | 08/20/2009 |
| 20090175935 | PHARMACEUTICAL COMPOSITIONS OF DULOXETINE The present invention relates to solid oral pharmaceutical compositions of duloxetine, process for preparing such compositions and method of using such compositions. Preferably, the invention relates to a delayed release composition of duloxetine comprising a core compr... | 07/09/2009 |
| 20090068260 | BETA-1-SELECTIVE ADRENOCEPTOR BLOCKING AGENT COMPOSITIONS AND METHODS FOR THEIR PREPARATION The present invention provides extended release pharmaceutical compositions of a beta blocker such as, but not limited to, metoprolol succinate as the active ingredient, optionally also comprising a diuretic such as but not limited to hydrochlorothiazide, and methods of... | 03/12/2009 |
| 20090053308 | Release-Control Composition The present invention relates to a controlled release capsule preparation for oral administration, which contains (i) a granule containing a physiologically active substance which is a compound represented by the formula: 02/26/2009 | |
| 20090017113 | DULOXETINE FORMULATIONS Duloxetine pellets having an enteric coating containing a polymethacrylate polymer can be formed with desirable release rates/profile and stability.... | 01/15/2009 |
| 20080317846 | Pulsatile release histamine H2 antagonist dosage form A unit dosage form, such as a capsule or the like, for delivering drugs into the body in a circadian release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. Each bead population exhibits a pre-design... | 12/25/2008 |
| 20080226711 | PHARMACEUTICAL COMPOSITIONS OF DULOXETINE The present invention relates to solid oral pharmaceutical compositions of duloxetine, process for preparing such compositions and method of using such compositions. Preferably, the invention relates to a delayed release composition of duloxetine comprising a core compr... | 09/18/2008 |
| 20080226712 | Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compo... | 09/18/2008 |
| 20080166405 | Abuse-resistant oral dosage forms and method of use thereof An opioid-antagonist oral dosage form which does not release a therapeutically effective amount of the opioid antagonist when the oral dosage form is orally administered to a human being, but whereby a physical alteration of the oral dosage form results in a release of ... | 07/10/2008 |
| 20070281007 | Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs Solid oral dosage formulations, such as tablet, mini-tab, multiparticulates or osmotic delivery systems, are coated with a mucoadhesive polymeric coating or formed of a mucoadhesive polymer to increase oral bioavailability of Biopharmaceutical Classification System (BCS... | 12/06/2007 |
| 20070264326 | Anti-misuse oral microparticle medicinal formulation The field of the present invention is that of solid microparticulate analgesic oral medicines. The invention is that of providing novel analgesic medicines which allow at the same time the prevention of misuse and of addiction to certain analgesics, and/or the control o... | 11/15/2007 |
